Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial

Massimo Mancone1, Rafael Cavalcante, Rodrigo Modolo

  • 1Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Abstract

Insights

Coronary artery bypass grafting (CABG) leads to more major infections than percutaneous coronary intervention (PCI) in multivessel coronary disease (MVD) patients. These infections increase the risk of death.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Clinical Trials

Background:

  • Multivessel coronary disease (MVD) management involves bypass surgery (CABG) and stenting (PCI).
  • Post-procedural infections are a known complication, but large randomized trial data on their incidence and impact after CABG vs. PCI for MVD is limited.

Purpose of the Study:

  • To determine the incidence of major infections following CABG and PCI in MVD patients.
  • To assess the association between these infections and long-term mortality.

Main Methods:

  • A post hoc analysis of the SYNTAX trial involving 1,800 MVD patients randomized to CABG or PCI.
  • Five-year follow-up to track the occurrence of major infections and all-cause mortality.

Main Results:

  • Major infections occurred in 15.8% of CABG patients versus 4.9% of PCI patients within five years.
  • Higher incidence of infection was observed early after CABG (HR 7.9, p<0.001).
  • Major infections were independently linked to a 2.6-fold increased risk of all-cause mortality (adjusted HR 2.6, p<0.001).

Conclusions:

  • Coronary artery bypass grafting (CABG) is associated with a significantly higher rate of major post-procedure infections compared to percutaneous coronary intervention (PCI).
  • Major infections following these procedures are an independent predictor of increased all-cause mortality.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K